Is Quest Diagnostics Incorporated overvalued?

Quest Diagnostics Incorporated (DGX) looks overvalued — trading about 27% above its fair value.

Overvalued

Price

$209.88

Fair value

$153.20

Current P/E

24.0

Normal P/E

17.5

Market cap

$23.23B

Dividend yield

1.8%

Return on equity

13.8%

Sector

Healthcare

Fair value compares DGX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks